UNH director granted 206 deferred stock units

Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director John H. Noseworthy received a grant of 206 shares of common stock in the form of deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 7,616 shares.

Insider Trade Summary

Grant/Award: 206 shares

Grant/Award 1 txn

Insider Noseworthy John H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	206	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,616 shares (Direct)

Footnotes (1)

1. F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Key Figures

Deferred stock units granted: 206 shares Holdings after transaction: 7,616 shares Grant price per share: $0.00 per share +1 more

4 metrics

Deferred stock units granted 206 shares Quarterly director compensation grant on 2026-07-01

Holdings after transaction 7,616 shares Total common stock directly held after grant

Grant price per share $0.00 per share Compensation award, not a market purchase

Transaction code A (Grant, award, or other acquisition) Non-derivative acquisition reported on Form 4

Key Terms

deferred stock units, regular quarterly compensation, immediately vested, Form 4

4 terms

deferred stock units financial

"Represents deferred stock units that are granted as regular quarterly compensation for service as a director"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

regular quarterly compensation financial

"deferred stock units that are granted as regular quarterly compensation for service as a director"

immediately vested financial

"Deferred stock units are immediately vested, but must be retained by the director"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UNH director John H. Noseworthy report?

John H. Noseworthy reported receiving 206 shares of UNITEDHEALTH GROUP INC common stock as deferred stock units. This was a regular quarterly compensation grant for his service as a director, not an open-market share purchase or sale.

How many UNITEDHEALTH GROUP INC shares does John H. Noseworthy hold after this Form 4?

After the grant, John H. Noseworthy holds 7,616 shares of UNITEDHEALTH GROUP INC common stock directly. These holdings include the 206 deferred stock units awarded as regular quarterly compensation for his ongoing service on the company’s Board of Directors.

Are the deferred stock units granted to UNH director John H. Noseworthy vested?

The deferred stock units granted to John H. Noseworthy are immediately vested upon grant. However, he must retain these units until he completes his service on the UNITEDHEALTH GROUP INC Board, limiting his ability to access them before leaving the Board.

Is John H. Noseworthy’s Form 4 transaction a stock purchase or sale of UNH shares?

The Form 4 transaction is neither a market purchase nor a sale. It reflects a grant of 206 deferred stock units as regular quarterly director compensation, with no price paid per share and no open-market trading involved in this reported transaction.

Why did UNITEDHEALTH GROUP INC grant 206 deferred stock units to John H. Noseworthy?

UNITEDHEALTH GROUP INC granted 206 deferred stock units to John H. Noseworthy as regular quarterly compensation for his Board service. This aligns director pay with company equity performance, while requiring the units to be held until his Board service is completed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Noseworthy John H

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		206(1)	A	$0	7,616	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for John H. Noseworthy M.D.	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)